Patents Assigned to @HEALTH
  • Patent number: 8224785
    Abstract: A network database system wherein clients of subscribing entities are authorized network access to reliable documents that are identified by each entity as being relevant to clients of that entity. Features that can be included in the system are customization of the documents to reflect sourcing by particular subscribers, automated formatting of the documents for storing in a network database, client access facilitated by subscriber-maintained databases, and the avoidance of cookies remaining on clients' computer hard drives following document access. Also disclosed is a method for processing repeated data requests on a distributed computer database.
    Type: Grant
    Filed: December 21, 2004
    Date of Patent: July 17, 2012
    Assignee: Health Informatics International, Inc.
    Inventors: Michael D. Myers, Charles R. Christian, Derrick K. Bennett, Mario C. Murga
  • Patent number: 8224051
    Abstract: A method for detecting a linear structure in a digital mammographic image, using a processor or computer at least in part, locates at least one microcalcification candidate cluster in the image data and extracts a first region of interest that encloses the at least one microcalcification candidate cluster. The first region of interest is processed to identify feature points that correspond to geometric structures in the first region of interest. A linear detection algorithm is applied by a repeated process that selects a line model from a predefined set of line models and analyzes the line model to determine whether a linear structure is present in the first region of interest.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: July 17, 2012
    Assignee: Carestream Health, Inc.
    Inventors: Shoupu Chen, Lawrence A. Ray
  • Patent number: 8224426
    Abstract: The present invention uses spectroscopic tissue volume measurements using non-ionizing radiation to detect pre-disease transformations in the tissue, which increase the risk for this disease in mammals. The method comprises illuminating a volume of selected tissue of a mammal with light having wavelengths covering a pre-selected spectral range, detecting light transmitted through, or reflected from, the volume of selected tissue, and obtaining a spectrum of the detected light. The spectrum of detected light is then represented by one or more basis spectral components, an error term, and an associated scalar coefficient for each of the basis spectral components. The associated scalar coefficient is calculated by minimizing the error term.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: July 17, 2012
    Assignee: University Health Network
    Inventors: Lothar Lilge, Brian C. Wilson, Michelle K. Nielsen
  • Patent number: 8224045
    Abstract: A method is disclosed for processing of images to detect dental caries, that includes the following steps. Directing incident light (16) toward a tooth (20), where this light excites a fluorescent emission from the tooth. Obtaining a fluorescence image (35) from the fluorescent light component (19), and obtaining a reflectance image (34) from the back-scattered light (18) from the tooth. Applying a color balance operation to the reflectance image. Removing the specular reflectance components from the color balanced reflectance image (82) to give a back-scattered reflectance image (50). Registering the fluorescent image with the back-scattered reflectance image. Combining the registered fluorescent image (115) with the back-scattered reflectance image to provide a diagnostic image (52).
    Type: Grant
    Filed: January 17, 2007
    Date of Patent: July 17, 2012
    Assignee: Carestream Health, Inc.
    Inventors: Peter D. Burns, Victor C. Wong, Mark E. Bridges, Rongguang Liang
  • Patent number: 8222225
    Abstract: Methods are disclosed for treating, preventing or reducing the risk of developing occupational lung diseases, such as pneumoconiosis. In several embodiments, the methods include administering a therapeutically effective amount of the suppressive ODN to a subject having or at risk of developing a pneumoconiosis, thereby treating or inhibiting the pneumoconiosis. In several examples, thee subject can have or be at risk of developing silicosis, asbestosis or berryliosis. The method can include selecting a subject exposed to, or at risk of exposure to, inorganic particles, including, but not limited to silica, asbestos, berrylium, coal dust, or bauxite.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: July 17, 2012
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Dennis M. Klinman, Takashi Sato
  • Patent number: 8221777
    Abstract: Methods are provided for producing a bioscaffold from natural tissues by oxidizing a decellularized tissue to produce a bioscaffold having pores therein. The pore size and porosity is increased to better accommodate intact cells so that live cells can better infiltrate and inhabit the bioscaffold. The bioscaffold may be freeze-dried or lyophilized, sterilized and (optionally) aseptically packaged for subsequent use. A further aspect of the present invention is a bioscaffold produced by the processes described herein. Methods of treatment using the bioscaffold as a graft or as a biomedical implant for implantation are also provided. Also provided are methods of seeding a bioscaffold with mammalian cells, wherein the seeding carried out either in vitro or in vivo, and wherein a bioscaffold produced as described herein is utilized for said seeding.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: July 17, 2012
    Assignee: Wake Forest University Health Sciences
    Inventors: Mark E. Van Dyke, George J. Christ, Patrick W. Whitlock
  • Patent number: 8222901
    Abstract: A system and method for intracorporeal elastography include an intra-luminal vibratory member configured to be positioned within a lumen of an imaging subject and configured to impart mechanical energy into tissue of the lumen. In a preferred embodiment, an external piezoelectric energy source is included and coupled to the vibratory member and configured to cause the vibratory member to longitudinally vibrate, thereby generating shear waves for use with magnetic resonance elastography.
    Type: Grant
    Filed: August 20, 2009
    Date of Patent: July 17, 2012
    Assignee: Sunnybrook Health Sciences Centre
    Inventors: Rajiv Chopra, Michael John Bronskill, Arvin Forghanian-Arani
  • Patent number: 8221768
    Abstract: The present invention encompasses isolated nucleic acids containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus or of a chimeric immunogenic flavivirus antigen comprising sequence from more than one flavivirus. The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. The invention also provides antigens encoded by nucleic acids of the invention, antibodies elicited in response to the antigens and use of the antigens and/or antibodies in detecting flavivirus or diagnosing flavivirus infection.
    Type: Grant
    Filed: October 15, 2009
    Date of Patent: July 17, 2012
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
    Inventor: Gwong-Jen J. Chang
  • Publication number: 20120178696
    Abstract: The present invention provides AMPAR excitotoxicity mediating polypeptides comprising the GluR2 NT1-3-2 (Y142-K172) amino acid sequence (SEQ ID NO:1) or the GAPDH(2-2-1-1) (I221-E250)amino acid sequence (SEQ ID NO:2). Also disclosed are nucleotide sequences encoding the polypeptides, methods of inhibiting GAPDH association with the GluR2 subunit or p53. Methods of inhibiting AMPA receptor mediated excitotoxicity using the polypeptides and nucleic acids are also disclosed.
    Type: Application
    Filed: January 4, 2012
    Publication date: July 12, 2012
    Applicant: CENTRE FOR ADDICTION AND MENTAL HEALTH
    Inventor: Fang LIU
  • Publication number: 20120177567
    Abstract: The present invention provides methods for the treatment of acute lymphoblastic leukemia (ALL) in pediatric patients using an anti-CD22 immunotoxin. The methods disclosed comprise administering to a pediatric patient in need of that treatment an effective dose of a recombinant immunotoxin comprising a variable light (VL) chain linked to a variable heavy (VH) which is genetically fused to a therapeutic moiety comprising a Pseudomonas exotoxin A PE38 fragment. The recombinant immunotoxin specifically binds CD22 thereby inhibiting the growth of CD22-expressing (CD22+) ALL cancer cells.
    Type: Application
    Filed: August 11, 2011
    Publication date: July 12, 2012
    Applicants: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT, MEDIMMUNE, LLC
    Inventors: Alan S. WAYNE, Ira Pastan, Karen Kaucic, Robert Lechleider
  • Publication number: 20120177675
    Abstract: The present invention provides a chimaeric coronavirus S protein which is based on an S protein from a coronavirus strain with restricted tissue tropism, but which comprises at least part of the S2 subunit from a coronavirus strain with extended tissue tropism, such that a virus comprising the chimaeric S protein has extended tissue tropism. The present invention also provides a virus comprising such a chimaeric S protein.
    Type: Application
    Filed: July 5, 2010
    Publication date: July 12, 2012
    Applicant: INSTITUTE FOR ANIMAL HEALTH
    Inventors: Paul Britton, Erica Bickerton, Maria Armesto
  • Publication number: 20120174325
    Abstract: Embodiments herein provide a modular gutter for use by bicycles and other conveyances. When utilized, a conveyance may be guided along the gutter either by an individual on the conveyance or adjacent to it, whether up or down the gutter. The gutter may be manufactured in various lengths and arrangements, and additionally, the components of the gutter are designed to permit multiple subunits to be coupled to form longer gutters. Alternatively, the gutters may be cut to a desired length should the manufactured length be too long. Thus, the gutter may be sized for any of a variety of staircases. The gutter may be removably installed on existing staircases without the need to redesign or reconstruct the staircase.
    Type: Application
    Filed: January 7, 2011
    Publication date: July 12, 2012
    Applicant: Oregon Health & Science University
    Inventors: Christopher Woo, Gary Granger
  • Patent number: 8217026
    Abstract: The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: July 10, 2012
    Assignees: Aeolus Sciences, Inc., National Jewish Health, Duke University
    Inventors: James D. Crapo, Brian J. Day, Michael P. Trova, Polvina Jolicia F. Gauuan, Douglas B. Kitchen, Irwin Fridovich, Ines Batinic-Haberle
  • Patent number: 8216788
    Abstract: The present disclosure relates to methods and compositions for the detection of infectious proteins or prions in samples, including the diagnosis of prion related diseases. One embodiment is an ultrasensitive method for detecting PrP-res (PrPSc) that allows the use of recombinant PrP-sen (rPrP-sen) as a substrate for seeded polymerization. A sample is mixed with purified rPrP-sen to make a reaction mix which is incubated to permit aggregation of the rPrP-sen with the PrP-res that may be present in the sample. Any aggregates are intermittently disaggregated by agitation (for example by sonication) and the reaction allowed to proceed to amplify target substrate. Any rPrP-res(Sc) in the reaction mix is detected to indicate the presence of PrP-res in the original sample. This assay, which is called rPrP-PMCA, is surprisingly much faster than existing PMCA methods, yet it still retains sufficient sensitivity to detect extremely low levels of PrP-res.
    Type: Grant
    Filed: July 21, 2008
    Date of Patent: July 10, 2012
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Byron W. Caughey, Ryuichiro Atarashi, Roger A. Moore
  • Patent number: 8216565
    Abstract: The invention provides human cells, particularly human T cells, comprising a murine T Cell Receptor (TCR) having antigen specificity for the cancer antigen gp100. Isolated or purified TCRs having antigenic specificity for amino acids 154-162 of gp100 (SEQ ID NO: 1), as well as related polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, or antigen binding fragments thereof, conjugates, and pharmaceutical compositions, are further provided. The invention further provides a method of detecting the presence of cancer in a host and a method of treating or preventing cancer in a host comprising the use of the inventive materials described herein.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: July 10, 2012
    Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
    Inventors: Nicholas P. Restifo, Lydie Cassard, Zhiya Yu, Steven A. Rosenberg
  • Patent number: 8217222
    Abstract: A method is described to identify secreted proteins identified with stages of malignancy of cancer. The proteins are initially identified by trapping them with a fluorescent protein containing vector that can insert in any gene. The secreted proteins are initially identified by their fluorescence. Secreted proteins identifying tumors with specific degrees of malignancy are isolated to determine if they can serve as markers of cancer progression.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: July 10, 2012
    Assignees: Anticancer, Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: Mingxu Xu, Yuying Tan, Levy Kopelovich
  • Patent number: 8219180
    Abstract: The present invention provides systems, devices, and methods employing fiber optic shape and position tracking. The systems, devices, and methods permit measurement of and continuous tracking of the shape and position of objects whose shape dynamically changes with time. Applications include tracking and monitoring of endoscopes for diagnostic and surgical procedures.
    Type: Grant
    Filed: October 9, 2008
    Date of Patent: July 10, 2012
    Assignees: Tufts University, University Health Network, The Governing Council of the University of Toronto
    Inventors: Caroline G. L. Cao, Peter Y. Wong, Lothar Lilge, Paul Milgram
  • Patent number: 8216549
    Abstract: A quantum dot (QD) conjugate comprises a QD and a ligand conjugated with the QD, in which the ligand has at least one thiol and at least one other functional group. The QD conjugate may further comprise a bioactive agent covalently coupled to the ligand to form a bioactive agent-tagged QD conjugate. A method for preparing a QD conjugate comprises the steps of: (1) providing a solution comprising a QD encapsulated within a dendrimer; (2) adding into the solution a ligand; and (3) allowing an exchange between the ligand and the dendrimer for the QD to obtain a ligand-QD conjugate, in which the ligand is covalently conjugated to the surface of the QD. The method may further comprise the step of coupling the ligand-QD conjugate to a bioactive agent to obtain a bioactive agent-tagged ligand-QD conjugate.
    Type: Grant
    Filed: June 17, 2009
    Date of Patent: July 10, 2012
    Assignee: National Health Research Institutes
    Inventors: Shu-Yi Lin, Leu-Wei Lo, Chung-Shi Yang
  • Patent number: 8217024
    Abstract: The present invention is directed to monophasic pharmaceutical compositions comprising a conjugated estrogen and a hydrophilic or lipophilic excipient. The present invention is also directed to kits and applicators comprising the pharmaceutical compositions. The invention is also directed to methods for treating menopausal conditions in a female comprising administration of the pharmaceutical compositions.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: July 10, 2012
    Assignee: Teva Women's Health, Inc.
    Inventors: Salah U. Ahmed, Madhu Sudhan Shaik, Sanjeev K. Gupta
  • Patent number: 8218004
    Abstract: A displacement sensing system is disclosed. Two image capturing devices are settled at to opposite ends of a coordinate axis of the planar area, respectively, for capturing images of the planar area and an object placed thereon. Four pre-established LUT databases and an interactive four-matrix lookup table process are implemented to determine actual coordinates of the object on in the planar area.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: July 10, 2012
    Assignee: Cycling & Health Tech Industry R&D Center
    Inventors: Chern-Sheng Lin, Chia-Tse Chen, Tzu-Chi Wei, Wei-Lung Chen, Chia-Chang Chang